H2020 project on In-silico Development- and Clinical-Trial-Platform for Testing in-situ Tissue Engineered Heart Valves
Joined February 2021
- Tweets44
- Following100
- Followers72
- Likes251
🚀 #SimInSitu Update!
We’re closing the year with 10 peer-reviewed publications on THV testing and patient-specific modeling!
In 2025, expect more on:
✅ Tissue regeneration
✅ FSI modeling
✅ VVUQ (ASME V&V 40)
Excited for what’s next! 🔬
#Innovation #VVUQ #FSI #H2020
Exciting progress in the H2020 #SimInSitu project!
We validated a patient-specific TAVI model for testing tissue-engineered heart valves (THVs), achieving <10% error in structural predictions. This sets the stage for evaluating Xeltis' biodegradable TAVI device! 🚀
#TAVI
Milestone #8 achieved! The Sapien-3 ETR heart valve model is now verified and validated within the SimInSitu project. Using in-silico methods and validated components, we’re pushing innovation in valve design. Sensitivity & uncertainty analyses add robustness. #SimInSitu
Excited to announce Milestone #15: successful patient-specific modeling of tissue-engineered heart valves in young patients! #medicalinnovation #milestone
🎉 Milestone Alert! SimInSitu project achieves breakthrough in TAVI evaluation with patient-specific simulations. Using SAPIEN 3 device, we've virtually treated aortic valve stenosis. Tailored simulations align closely with clinical outcomes. #TAVI #MedicalSimulation
Join us at #VPH2024 in Stuttgart, Germany! 🇩🇪 SIMCor, SimInSitu, and SimCardioTest are teaming up to host a session on cardiovascular modeling. Abstract submission deadline extended to 22 MARCH. Don't miss out – submit your paper now! vph.tik.uni-stuttgart.de
Exciting news: Leartiker researchers uncover insights into scaffold material fatigue, aiding biomedical advancements. #MaterialScience #BiomedicalEngineering 🧪🔬
"🎉 SimInSitu Project Milestone! 🏥 Validated S3 TAVI Device FSI Model using SPH method in Abaqus. Achieved <10% error, robust for patient-specific simulations. 🌐 #SimInSitu #MedicalSimulation"
siminsitu retweeted
📅 Join us on Feb 6-7, 2024, in #Leuven, #Belgium for #InnovaHeart2024! This European workshop focuses on #digitalheart innovations in cardiovascular medicine, uniting academics, start-ups, and industry leaders in in-silico modeling. #cardiovascular #simulation #research
📅 Join us on Feb 6-7, 2024, in #Leuven, #Belgium for #InnovaHeart2024! This European workshop focuses on #digitalheart innovations in cardiovascular medicine, uniting academics, start-ups, and industry leaders in in-silico modeling. #cardiovascular #simulation #research
At TU-Graz, our research group just released two groundbreaking papers on electrospun polymers for Xeltis' heart valves. These studies tackle complex biomechanical issues and provide valuable insights. Dive in looking at our Newsletter: siminsitu.eu/blog
Look at our an in-silico model of Pulmonary Heart Valve. More informatio at our website siminsitu.eu/
siminsitu retweeted
4RealSim, as the SimInSitu - In-silico Development- and Clinical-Trial-Platform Consortium leader, is excited to share with you the invitation to the INNOVAHEART workshop.
This event is organized by our fellow SimCardioTest EU project eHealth_EU consort…lnkd.in/ecrbRa4r
siminsitu retweeted
Save the date: 22 March 2023 in Bordeaux, France.
For the first time, five EU funded projects join their forces to bring together different actors of the #insilico #cardiovascular ecosystem, during a one-day workshop.
more information on: bit.ly/innovaheart
The MS2 milestone successfully concludes the scaffold characterisation and Uncertainty Quantification (Epistemic and Aleatoric uncertainty) of three scaffold materials used in Xeltis for in-situ tissue-engineered heart valves in WP1
siminsitu retweeted
#VPH2022 is great science, hands-on workshops, student activities, community and networking... all of this in the amazing setting of one of the most charming cities of Portugal: Porto 🌉🍷💯
We are waiting for you there!